Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
Address
Grand Plaza, Office Tower Two
Kowloon,
Hong Kong
Phone
864358218333
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
745
First IPO Date
May 24, 2001
| Name | Title | Pay | Year Born |
| Hong Zhang | Executive Chairman, Chief Executive Officer & Compliance Officer | 933,557 | 1955 |
| Xiang Fu Xu | Deputy Technical GM & Executive Director | 245,551 | 1971 |
| Guo Wen Wu | Deputy Sales Director & Executive Director | 369,485 | 1965 |
| Yi Zhang | Executive GM & Executive Director | 445,930 | 1982 |
| Bao Gang Zhao | Chief Financial Officer & Executive Director | 495,735 | 1967 |
| Xiao Guang Zhang | GM & Executive Director | 553,648 | 1964 |
| Sai Cheong Mok ACCA FCCA | Company Secretary | 0 | 1980 |
Jilin Province Huinan Changlong Bio-pharmacy Company Limited focuses on the manufacturing and sale of traditional Chinese medicines and various pharmaceutical products within the People's Republic of China. The company's extensive product portfolio includes a wide range of dosage forms such as tablets, capsules, and pills, as well as specialized items like Chinese medicine pretreatment and extraction products. They also provide various injectable solutions, including powders for injection, lyophilized powders for injection, and small volume liquid injections, along with active pharmaceutical ingredients (APIs) and granules. These products are primarily sold under the "Changlong" and "Qing Tong" brand names. Established in 1989, and headquartered in Kowloon, Hong Kong, the company was previously known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited.